western therapy
PreclinicalSmall molecule
western therapy is one of 22 small molecule programs targeting Influenza. It is currently in Preclinical.
1
Indications
4
Total Trials
0
Active Trials
21
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1053 competitors in Influenza
#DrugCompanyPhaseTrials
1Fluzone
GSKPreclinical
Trexall
Alnylam PharmaceuticalsPreclinical
Crestor
AstraZenecaPreclinical
Avigan
AAppili Therapeutics Inc.
Preclinical
Quadrivalent Influenza Vaccine
SanofiPreclinical
COMIRNATY
PfizerPreclinical
Antihistamine
Arrowhead PharmaceuticalsPreclinical
Focetria
CChiltern Pesquisa Clinica Ltda
Preclinical
Influenza A/H5N1
NNational Institute of Allergy and Infectious Diseases (NIAID)
Preclinical
Fluvirin
NovartisPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Influenza1 trial
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
Unknown status·—·N/A·NCT01053533·1,100 enrolled
Double-blind1 trial
Herbal Medicine1 trial
A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Unknown status·—·N/A·NCT01145664·390 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for western therapy. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details